Nicholas Hollmeyer Lynton - Apr 1, 2023 Form 4/A - restatement Insider Report for Cardlytics, Inc. (CDLX)

Role
Chief Legal & Privacy Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Apr 1, 2023
Transactions value $
$0
Form type
4/A - RESTATEMENT
Date filed
7/7/2023, 04:19 PM
Date Of Original Report
Apr 4, 2023
Previous filing
Jan 13, 2023
Next filing
Apr 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Units -Options Exercise $0 -2,324 -24.99% $0.00 6,975 Apr 1, 2023 Common Stock 2,324 Direct F1, F2, F3, F4

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Twenty-five percent (25%) of the shares under this award vest on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date.
F3 The initial Form 4 misreported the vesting schedule of this RSU award. This represents the correct vesting schedule.
F4 The initial Form 4 misreported the number of securities beneficially owned after the transaction. This represents the correct number of securities beneficially owned after the transaction.